Thermo Fisher to Buy Coronavirus Tester Qiagen for $10 Billion

The video discusses the acquisition deal between Thermo Fisher and Kigen, highlighting how the coronavirus pandemic influenced the negotiations. Initially, talks broke down, but Thermo Fisher re-engaged with Kigen, leading to a deal at a price of $43 per share, which is a 30% premium. The acquisition, valued at $10 billion, is the largest healthcare acquisition of 2020. Despite potential interest from other companies, a bidding war is unlikely due to the structured breakup fee.

What impact did the cancellation of the deal talks have on people's holidays?

What was the reason given by Thermo CEO for the deal happening now?

How did the uncertainty affect the negotiations between the two companies?

What was the initial bid from Thermo Fisher late last year?

What is the significance of the $10 billion purchase in the context of healthcare acquisitions in 2020?